Drug Shortage Report for EDARBYCLOR
Report ID | 83479 |
Drug Identification Number | 02397749 |
Brand name | EDARBYCLOR |
Common or Proper name | EDARBYCLOR |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | CHLORTHALIDONE Azilsartan Medoxomil |
Strength(s) | 12.5MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28ct |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-06-30 |
Actual start date | |
Estimated end date | 2019-08-31 |
Actual end date | 2019-05-21 |
Shortage status | Avoided shortage |
Updated date | 2019-05-23 |
Company comments | anticipated |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-05-23 | French | Compare |
v3 | 2019-05-23 | English | Compare |
v2 | 2019-05-08 | French | Compare |
v1 | 2019-05-08 | English | Compare |
Showing 1 to 4 of 4